Atlas Trials

Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery

Clinical trial NCT06490718 · COMPLETED

Trial details

NCT number
NCT06490718
Sponsor
Chinese University of Hong Kong
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2024-10-25
Primary completion
2025-07-17
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.